| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Property and equipment, net | 59,789 | |||
| Prepaid expenses and other current assets | 204,926 | |||
| Cash and cash equivalents | 588,775 | |||
| Accounts receivable, net of allowance for doubtful accounts of 638,012 and 620,433 at june 30, 2025 and december 31, 2024, respectively | 372,469 | |||
| Total current assets | 1,166,170 | |||
| Security deposits | 12,100 | |||
| Other intangible assets, net | 620,923 | |||
| Operating lease right-of-use asset | 299,001 | |||
| Internally developed software, net | 3,876,518 | |||
| Total assets | 6,034,501 | |||
| Operating lease current obligation | 46,982 | |||
| Deferred revenue | 164,066 | |||
| Accrued expenses | 645,567 | |||
| Accounts payable | 4,315,010 | |||
| Total current liabilities | 5,171,625 | |||
| Operating lease long-term obligation | 240,903 | |||
| Total liabilities | 5,412,528 | |||
| Treasury stock, 1,550 shares at june 30, 2025 and december 31, 2024, at cost | 172 | |||
| Accumulated deficit | -74,568,256 | |||
| Common stock, 0.0001 par value, 200,000,000 shares authorized, 2,498,423 issued and 2,496,873 outstanding at june 30, 2025 and 1,698,454 issued and 1,696,904 outstanding at december 31, 2024 | 250 | |||
| Additional paid-in capital | 75,190,151 | |||
| Accumulated other comprehensive income | 0 | |||
| Total stockholders equity | 621,973 | |||
| Total liabilities and stockholders equity | 6,034,501 | |||
iSpecimen Inc. (ISPC)
iSpecimen Inc. (ISPC)